ESC 365 - Evidence of early bioprosthetic valve dysfunction after TAVR in aortic valve stenosis during one-year follow-up according to VARC-3

ESC Professional Premium Access

Evidence of early bioprosthetic valve dysfunction after TAVR in aortic valve stenosis during one-year follow-up according to VARC-3

Session: Technical aspects of TAVI and valve-in-valve procedures

Topic: Aortic Valve Intervention

Speaker: Ms J. Heermann (Duesseldorf, DE)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Ms Jacqueline Heermann

University Hospital Duesseldorf, Duesseldorf (Germany)

0 follower

7 more presentations in this session

Sutureless and rapid-deployment versus conventional bioprosthetic aortic valve replacement in patients with aortic stenosis: a systematic review and meta-analysis of randomised controlled trials

Speaker: Mr J. Yadee (Chiang Mai, TH)

Self-expanding or balloon-expandable transcatheter aortic valve replacement in a German comparison

Speaker: Doctor V. Oettinger (Freiburg, DE)

Pressure-regulated deployment for balloon-expandable TAVI is safe, effective and results in superior valve haemodynamics regardless of prosthesis size

Speaker: Doctor A. Snir (Sydney, AU)

Valve-in-valve transcatheter aortic valve implantation for degenerative stentless versus stented surgical bioprostheses

Speaker: Mr J. Steul (Dresden, DE)

Vascular closure after TAVI: assessing the safety and efficacy of a collagen-based device in a real-world population

Speaker: Doctor M. Grine (Coimbra, PT)

Access the full session

Technical aspects of TAVI and valve-in-valve procedures

Speakers: Ms J. Heermann, Mr J. Yadee, Doctor V. Oettinger, Doctor A. Snir, Mr J. Steul...

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources